Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating Activities:      
Net income $ 1,104 $ 1,066 $ 598
Less: Income from discontinued operations, net of tax 0 (775) (169)
Income from continuing operations 1,104 291 429
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (143) (42) (54)
Unrealized losses on fair value adjustments to Venator investment and related loss on disposal 28 88 19
Cash received from return on investment in unconsolidated subsidiary 57 19 24
Depreciation and amortization 296 283 270
Noncash lease expense 69 63 55
Gain on disposal of businesses/assets (28) (281) (49)
Loss on early extinguishment of debt 27 0 23
Noncash restructuring and impairment charges 19 7 3
Deferred income taxes (37) 172 (93)
Stock-based compensation 32 27 29
Other, net (10) 8 20
Changes in operating assets and liabilities:      
Accounts and notes receivable (315) 100 138
Inventories (367) 145 77
Receivable associated with the Albemarle Settlement (333) 0 0
Other current assets 39 (65) 26
Other noncurrent assets (189) (55) (90)
Accounts payable 342 32 21
Accrued liabilities 293 (126) (50)
Taxes paid on Chemical Intermediates Businesses 0 (231) 0
Other noncurrent liabilities 69 (158) (142)
Net cash provided by operating activities from continuing operations 953 277 656
Net cash (used in) provided by operating activities from discontinued operations (1) (24) 241
Net cash provided by operating activities 952 253 897
Investing Activities:      
Capital expenditures (342) (249) (274)
Cash received from sale of businesses 43 2,181 0
Acquisition of businesses, net of cash acquired (245) (650) 0
Cash received from the sale of Venator shares 0 99 0
Proceeds from sale of assets 0 75 50
Cash received from forward swap contract related to the sale of investment in Venator 0 0 16
Insurance proceeds for recovery of property damage 8 0 0
Other 12 6 7
Net cash (used in) provided by investing activities from continuing operations (524) 1,462 (201)
Net cash provided by (used in) investing activities from discontinued operations 0 1 (59)
Net cash (used in) provided by investing activities (524) 1,463 (260)
Financing Activities:      
Net repayments on revolving loan facilities (8) (203) (89)
Proceeds from issuance of long-term debt 447 0 742
Repayments of long-term debt (990) (21) (676)
Repayments of short-term debt 0 (109) 0
Borrowings on short-term debt 0 0 102
Repayments of notes payable 0 (32) (27)
Borrowings on note payable 0 0 37
Debt issuance costs paid (4) 0 (8)
Costs of early extinguishment of debt (26) 0 (21)
Dividends paid to common stockholders (159) (144) (150)
Dividends paid to noncontrolling interests (40) (44) (41)
Cash paid for noncontrolling interest 0 0 (101)
Repurchase of common stock (200) (96) (208)
Repurchase and cancellation of stock awards (7) (8) (12)
Proceeds from issuance of common stock 10 3 2
Other 0 (1) 0
Net cash used in financing activities (977) (655) (450)
Effect of exchange rate changes on cash (3) 7 (2)
(Decrease) increase in cash and cash equivalents (552) 1,068 185
Cash and cash equivalents from continuing operations at beginning of period 1,593 525 340
Cash and cash equivalents at end of period 1,041 1,593 525
Supplemental cash flow information:      
Cash paid for interest 82 90 111
Cash paid for income taxes 106 316 100
Huntsman International LLC [Member]      
Operating Activities:      
Net income 1,107 1,067 587
Less: Income from discontinued operations, net of tax 0 (775) (169)
Income from continuing operations 1,107 292 418
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (143) (42) (54)
Unrealized losses on fair value adjustments to Venator investment and related loss on disposal 28 88 19
Cash received from return on investment in unconsolidated subsidiary 57 19 24
Depreciation and amortization 296 283 270
Noncash lease expense 69 63 55
Gain on disposal of businesses/assets (28) (281) (49)
Loss on early extinguishment of debt 27 0 23
Noncash restructuring and impairment charges 19 7 3
Deferred income taxes (38) 172 (91)
Other, net (12) 8 36
Noncash compensation 31 26 28
Changes in operating assets and liabilities:      
Accounts and notes receivable (315) 100 138
Inventories (367) 145 77
Receivable associated with the Albemarle Settlement (333) 0 0
Other current assets 47 (65) 21
Other noncurrent assets (189) (55) (90)
Accounts payable 339 30 7
Accrued liabilities 289 (126) (51)
Taxes paid on Chemical Intermediates Businesses 0 (231) 0
Other noncurrent liabilities 72 (154) (139)
Net cash provided by operating activities from continuing operations 956 279 645
Net cash (used in) provided by operating activities from discontinued operations (1) (24) 241
Net cash provided by operating activities 955 255 886
Investing Activities:      
Capital expenditures (342) (249) (274)
Cash received from sale of businesses 43 2,181 0
Acquisition of businesses, net of cash acquired (245) (650) 0
Cash received from the sale of Venator shares 0 99 0
Proceeds from sale of assets 0 75 50
Cash received from forward swap contract related to the sale of investment in Venator 0 0 16
Insurance proceeds for recovery of property damage 8 0 0
Other 13 7 7
Net cash (used in) provided by investing activities from continuing operations (726) 1,736 (202)
Net cash provided by (used in) investing activities from discontinued operations 0 1 (59)
Net cash (used in) provided by investing activities (726) 1,737 (261)
Increase in receivable from affiliate (203) 273 (1)
Financing Activities:      
Net repayments on revolving loan facilities (8) (203) (89)
Proceeds from issuance of long-term debt 447   742
Repayments of long-term debt (990) (21) (676)
Repayments of short-term debt 0 (109) 0
Borrowings on short-term debt 0 0 102
Repayments of notes payable 0 (32) (27)
Borrowings on note payable 0 0 37
Debt issuance costs paid (4) 0 (8)
Costs of early extinguishment of debt (26) 0 (21)
Dividends paid to noncontrolling interests (40) (44) (41)
Cash paid for noncontrolling interest 0 0 (101)
Other 1 0 (1)
Net cash used in financing activities (778) (933) (438)
Effect of exchange rate changes on cash (3) 7 (2)
(Decrease) increase in cash and cash equivalents (552) 1,066 185
Cash and cash equivalents from continuing operations at beginning of period 1,591 525 340
Cash and cash equivalents at end of period 1,039 1,591 525
Repayments of notes payable to affiliate 0 (380) (207)
Dividends paid to parent (158) (144) (148)
Supplemental cash flow information:      
Cash paid for interest 82 90 111
Cash paid for income taxes $ 106 $ 316 $ 100